<PAGE>
ELITRA PHARMACEUTICALS INC.
3510 DUNHILL STREET
SAN DIEGO, CA 92121
November 20, 2000
VIA FACSIMILE AND EDGAR TRANSMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W., Mail Stop 0309
Washington, D.C. 20549
Attn: Jeffrey P. Riedler
RE: ELITRA PHARMACEUTICALS INC.
REGISTRATION STATEMENT ON FORM S-1 (FILE NO. 333-45146)
REQUEST FOR WITHDRAWAL
Dear Mr. Riedler:
Pursuant to Rule 477 of the Securities Act of 1933, as amended, Elitra
Pharmaceuticals Inc. (the "Registrant") hereby requests withdrawal of its
Registration Statement on Form S-1 (SEC File No. 333-45146) filed with the
Commission on September 5, 2000, on the grounds that current market conditions
do not support a public offering of the Registrant's Common Stock at this time.
If you should have any questions regarding this application, please contact
Frederick T. Muto or Glenn F. Baity of Cooley Godward LLP at (858) 550-6000.
Sincerely,
ELITRA PHARMACEUTICALS INC.
By: /s/ Alana B. McNulty
-------------------------------------
Alana B. McNulty
Chief Financial Officer
cc: Harry F. Hixson, Jr., Ph.D.
Frederick T. Muto, Esq.
L. Kay Chandler, Esq.
Glenn F. Baity, Esq.
